O'Shaughnessy Asset Management’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History

O'Shaughnessy Asset Management’s Portfolio RVLP Stock Details RVLP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,299	Closed	-$4K	–	2662
2021 Q3	$4K	Hold	1,299	–	–	﹤0.01%	2400
2021 Q2	$4K	Hold	1,299	–	–	﹤0.01%	2224
2021 Q1	$4K	Hold	1,299	–	–	﹤0.01%	1991
2020 Q4	$5K	Hold	1,299	–	–	﹤0.01%	1692
2020 Q3	$7K	Hold	1,299	–	–	﹤0.01%	1445
2020 Q2	$9K	Buy	+1,299	New	+$6.36K	﹤0.01%	1284
2020 Q1	–	Sell	-2,834	Closed	-$20K	–	1910
2019 Q4	$20K	Buy	+2,834	New	+$15.1K	﹤0.01%	1150

Other funds holding RVLP

ACM

Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return

Rovida Advisors Fort Lauderdale, Florida $116M AUM 12.52% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

O'Shaughnessy Asset Management's RVLP Position: Q4 2021 in Review

O'Shaughnessy Asset Management sold out of RVL Pharmaceuticals plc Ordinary Shares (RVLP) in Q4 2021, closing a stake of 1,299 shares — an estimated $4K sold.

O'Shaughnessy Asset Management first reported a position in RVLP in Q4 2019 and held it in 7 quarters. The position peaked at $20K in Q4 2019. 31 funds tracked by Wall St. Rank hold RVLP as of Q4 2021.

O'Shaughnessy Asset Management reported no remaining RVL Pharmaceuticals plc Ordinary Shares position as of Q4 2021 after selling out during the quarter.
O'Shaughnessy Asset Management sold 1,299 RVL Pharmaceuticals plc Ordinary Shares shares in Q4 2021, an estimated $4K.
O'Shaughnessy Asset Management first reported a position in RVL Pharmaceuticals plc Ordinary Shares in Q4 2019 and held it in 7 quarters.
O'Shaughnessy Asset Management's RVL Pharmaceuticals plc Ordinary Shares position peaked at $20K in Q4 2019.
31 funds tracked by Wall St. Rank held RVL Pharmaceuticals plc Ordinary Shares as of Q4 2021.

Based on O'Shaughnessy Asset Management's 13F filing for Q4 2021, filed 11 Feb 2022.